Evommune, Inc. (EVMN)
NYSE: EVMN · USD
$11.1
-0.20 (-1.8%)· Recorded snapshot
Coverage state: Market snapshot only — no published research
Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.
On-demand research
Generate the first EVMN analysis
Start the full research workflow when this ticker is ready in our data system.
| Market cap | 398M | |
|---|---|---|
| Revenue (ttm) | 10M | |
| Net income (ttm) | -76M | |
| EPS (ttm) | -$5.36 | |
| Shares out | 36M | |
| Volume | 308,007 | |
| Price target | $31.1 | +181.8% |
Market data
Price
Recent price action with selectable time range.
Financial snapshot
- Revenue (ttm)
- 10M
- Net income (ttm)
- -76M
- EPS (ttm)
- -$5.36
- Market cap
- 398M
Fair-value bridge
- Current price
- $11.1
Analyst consensus
Recommendation
Buy
Price target
$31.1
+181.8%
In the news
Latest news · EVMN
Recent company headlines from major financial publishers.
Valuation
- Market cap
- 398M
- P/S
- 39.8x
- P/B
- 1.3x
Profitability
- Gross margin
- 100.0%
- Operating margin
- -899.9%
- ROE
- -45.0%
- ROA
- -29.7%
- ROIC
- -32.3%
Balance sheet
- Debt / equity
- 0.03
- Current ratio
- 20.36
- Quick ratio
- 19.94
Trading
- Volume
- 308,007
- Dividend yield
- 0.0%